Today: 30 April 2026
Browse Category

TSX:2344.TW 20 January 2026 - 1 February 2026

Winbond stock price: Taiwan’s 2344 faces a key week as trading curbs near expiry

Winbond stock price: Taiwan’s 2344 faces a key week as trading curbs near expiry

Winbond closed at T$103, down 1.4% after volatile trading, and remains under Taiwan Stock Exchange disposal curbs through Jan. 26. The company reported December revenue of NT$9.77 billion, up 53% year-on-year. Traders are watching AI-driven memory demand and possible impacts on legacy chips. Winbond recently ordered NT$6.81 billion in production equipment from Lam Research.
26 January 2026
·

Stock Market Today

  • Standard Chartered Shares Surge on Record Q1: A FTSE 100 Banking Opportunity?
    April 30, 2026, 8:53 AM EDT. Standard Chartered (LSE: STAN) shares jumped 4% following a record first quarter, contrasting with losses seen in Lloyds Banking Group's stock despite better-than-expected results. CEO Bill Winters highlighted strong growth in Wealth Solutions and Global Banking, with full-year 2026 guidance maintained at 5%-7% operating income growth. The bank posted a 9% rise in operating profit to $5.9 billion and a 17% increase in pre-tax profit to $2.5 billion, despite $296 million in impairment charges linked to Middle East conflicts. Shares trade at a price-to-earnings ratio of 11, with a modest 2.6% dividend yield expected in 2026. Investors weigh the risks of emerging market exposure against steady profits and disciplined risk management.

Latest article

QUALCOMM Incorporated (QCOM) Stock Jumps as AI Data-Center Bet Offsets Weak Forecast

QUALCOMM Incorporated (QCOM) Stock Jumps as AI Data-Center Bet Offsets Weak Forecast

30 April 2026
Qualcomm shares rose 10.3% premarket Thursday after CEO Cristiano Amon said the smartphone market had bottomed and highlighted progress in data-center chips. Fiscal Q2 revenue fell 3% to $10.6 billion, with handset revenue down 13% but automotive up 38%. The Q3 forecast missed Wall Street estimates. Qualcomm expects chip sales to Chinese handset makers to recover after Q3.
Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

30 April 2026
Eli Lilly raised its 2026 revenue forecast by $2 billion after first-quarter sales jumped 56% to $19.8 billion, driven by Mounjaro and Zepbound, which brought in $12.8 billion. Adjusted earnings reached $8.55 per share. The company cited strong demand but noted lower realized prices and competition from Novo Nordisk remain risks. Foundayo, Lilly’s new oral GLP-1 pill, launched in April but was not included in the quarter’s results.
Go toTop